Despite representing a common and costly disease, substantial variation exists in the disposition of pediatric pneumonia from the emergency department (ED).1 Prognostic tools supplying objective risk information may improve decision-making. We previously developed and validated an electronic health record (EHR) pneumonia prognostic model to predict severe in-hospital outcomes.2,3 That model’s reliance on EHR data is critical for ease of implementation, but includes weak and problematic predictors, such as peripheral white blood cell (WBC) count and race, both poor differentiators of disease severity, and for race, a construct with little biologic relevance.2–5 This study updates and reexamines our EHR model, omitting WBC count and race.
Methods
Children enrolled in the Etiology of Pneumonia in the Community study (2010–2012) formed the development cohort.6 The validation cohort included children enrolled in a single-center observational pilot (2014–2017), followed by a 2-center observational cohort (2017–2019).3 Children aged <18 years presenting to the ED with signs and symptoms of acute lower respiratory tract infection, radiographic evidence of pneumonia, and a provider-confirmed diagnosis of pneumonia were included, as previously reported.2,3 All studies were approved by the institutional review board.
The original models included: (1) a full model of 20 predictors, (2) an expert model of 10 predictors based on expert opinion, and (3) an EHR model of 9 predictors available as coded EHR fields.2 Modeling used ordinal logistic regression to simultaneously estimate risk probabilities for (a) mild (ED discharge) or moderate (non-ICU admission), (b) severe (ICU admission), and (c) very severe (invasive mechanical ventilation and/or shock requiring vasoactive medications) disease. The EHR model predictors included sex, race, temperature, age, heart rate, respiratory rate, systolic blood pressure, WBC count, and ratio of PaO2 to fraction of inspired oxygen (P/F ratio).2,3 Race was categorized as non-Hispanic white, non-Hispanic Black, Hispanic, and other. In development and validation, all 3 models performed similarly, with the EHR model holding greatest promise for implementation.2,3 Notably, race and WBC count were not considered important predictors in the expert model and were omitted.
In this study, we compared the original EHR model to a modified EHR (mEHR) model removing race and WBC count. The original development cohort was used to reestimate model parameters for the mEHR model. Predictive performance was then estimated in the development and validation cohorts using discrimination (c-statistic) and calibration plots, with recalibration of intercepts and slopes where appropriate.
Results
The mEHR model demonstrated very good discrimination, with similar performance to the EHR model (c-statistic across models 0.77–0.80) in both developmental and validation cohorts (Table 1). Calibration was excellent (Fig 1).
Performance of Pediatric Pneumonia Prognostic Models
Prognostic Model . | Development Cohort . | Validation Cohort . | ||
---|---|---|---|---|
N . | C-Statistic (95% CI) . | N . | C-Statistic (95% CI) . | |
EHRa | 1902 | 0.770 (0.747–0.793) | 593 | 0.789 (0.753–0.825) |
mEHR | 2238 | 0.767 (0.744–0.789) | 1088 | 0.794 (0.764–0.825) |
Prognostic Model . | Development Cohort . | Validation Cohort . | ||
---|---|---|---|---|
N . | C-Statistic (95% CI) . | N . | C-Statistic (95% CI) . | |
EHRa | 1902 | 0.770 (0.747–0.793) | 593 | 0.789 (0.753–0.825) |
mEHR | 2238 | 0.767 (0.744–0.789) | 1088 | 0.794 (0.764–0.825) |
Calibration of pediatric pneumonia prognostic models. Calibration plot of mEHR. Solid line represents nonparametric smooth curve between observed proportion and predicted probability. Triangles based on patient deciles grouped by similar predicted probabilities. Spike histograms for mild/moderate subjects (top) and severe/very severe subjects (bottom). Maximum and mean absolute error (E-statistic) presented.
Calibration of pediatric pneumonia prognostic models. Calibration plot of mEHR. Solid line represents nonparametric smooth curve between observed proportion and predicted probability. Triangles based on patient deciles grouped by similar predicted probabilities. Spike histograms for mild/moderate subjects (top) and severe/very severe subjects (bottom). Maximum and mean absolute error (E-statistic) presented.
Discussion
Removing the problematic and weak predictors of race and WBC count from our previously validated pneumonia severity model retained usability and maintained prediction performance. The updated mEHR model represents a suitable alternative to the original EHR model, with important improvements in health equity and generalizability.
Race was considered in the original models because of known differences in invasive pneumococcal disease by race.7 However, race is a sociopolitical construct without a clear biologic basis and more closely aligns with social health determinants. Including race in risk prediction models may perpetuate biases.5 Exclusion of race in our model aligns with the retirement of the American Academy of Pediatrics’ urinary tract infection guidelines and replacement of race with fever duration in the University of Pittsburgh’s UTICalc Version 3.0.4,8,9 Critical evaluation of similar severity models for racial bias may further improve prediction and health equity.
Though WBC count is a common inflammatory biomarker associated with a variety of infectious diseases, studies have demonstrated weak associations with pneumonia disease severity.2,10 Further, because blood tests are not often performed in children with pneumonia, removal of WBC count better aligns with clinical practice, improving generalizability, and future clinical application.
Our study has limitations. Although an EHR-based strategy simplifies implementation, it risks constraining predictor selection. As a result, the mEHR model omits important predictors, such as chest indrawing. Our study was performed at tertiary care children’s hospitals and may lack generalizability.
Conclusions
The mEHR model removed 2 suboptimal predictors, but still performed similarly to the original EHR model. Application of the mEHR model is favored over the original EHR model for future risk stratification and decision-making in pediatric pneumonia.
Dr Sartori conceptualized and designed the study, drafted the initial manuscript, and reviewed and revised the manuscript; Drs Ampofo, Antoon, Arnold, Grijalva, Pavia, and Williams designed the study, and reviewed and revised the manuscript; Drs Nian and Zhu designed data collection tools, performed statistical calculations and modeling, and reviewed and revised the manuscript; Mr Johnson and Ms Stassun designed, coordinated, and supervised data collection, and critically reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
FUNDING: Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases K23 AI168496 (Dr Antoon), K24 AI148459 (Dr Grijalva), K23 AI104779 (Dr Williams), and R01 AI125642 (Dr Williams). The National Institutes of Health did not have any role in the design or conduct of the study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
CONFLICT OF INTEREST DISCLOSURES: Dr Grijalva has received consulting fees from Merck. Dr Williams has received in-kind research support from BioMérieux. The other authors have indicated they have no conflicts of interest relevant to this article to disclose.
Comments